CD7+ T-ALL/LBL

Clinical trials for CD7+ T-ALL/LBL explained in plain language.

Never miss a new study

Get alerted when new CD7+ T-ALL/LBL trials appear

Sign up with your email to follow new studies for CD7+ T-ALL/LBL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells target hidden leukemia after transplant

Disease control Recruiting now

This early-phase study tests whether specially engineered immune cells (CAR-T cells) can eliminate small amounts of leftover T-cell leukemia or lymphoma in patients who have already received a stem cell transplant. About 18 participants will receive the treatment and be monitored…

Matched conditions: CD7+ T-ALL/LBL

Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

CD7+ T-ALL/LBL

Get alerted when new CD7+ T-ALL/LBL trials appear

Engineered immune cells target hidden leukemia after transplant